Home> Products> moderate ulcerative colitis

{ "products": [ { "_id": "6661a73687f0960e14a2c739", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "mycophenolate sodium 360 mg", "description": "MYCOPLASM S 360 \nMycophenolate sodium 360 mg is an essential immunosuppressant medication designed to prevent organ transplant rejection, particularly for kidney, heart, and liver transplants. As the sodium salt of mycophenolic acid, it delivers 360 mg of the active moiety per tablet, providing targeted immune suppression to help patients maintain their new organs long-term. This product stands out for its enteric-coated formulation, which enhances gastrointestinal tolerability compared to other forms, making it a preferred choice in post-transplant care regimens.​\n\nUses of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg primarily serves as a prophylactic agent against acute rejection in adult and pediatric patients receiving allogeneic renal, cardiac, or hepatic transplants. It works alongside other immunosuppressants like cyclosporine and corticosteroids to create a balanced regimen that minimizes the risk of graft loss. Clinically, it proves effective in de novo transplant recipients, where starting therapy early post-surgery significantly reduces rejection episodes. Beyond transplants, off-label applications include managing refractory autoimmune conditions such as lupus nephritis or myasthenia gravis, where immune overactivity damages tissues.​\n\nThe drug targets the proliferation of T- and B-lymphocytes, key players in immune responses that can attack transplanted organs. In renal transplant patients, for instance, it helps preserve kidney function by curbing antibody-mediated rejection. Its role extends to maintenance therapy, where consistent dosing sustains immunosuppression without excessive toxicity. Healthcare providers often adjust it based on patient response and trough levels of the active metabolite, mycophenolic acid (MPA), ensuring optimal therapeutic outcomes.​\n\nKey Benefits of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg offers several advantages that make it a cornerstone in transplant medicine. One primary benefit is its selective inhibition of lymphocyte proliferation, sparing other cell types and reducing broad-spectrum immunosuppression risks. This leads to fewer opportunistic infections compared to older agents like azathioprine. The enteric coating minimizes upper GI upset, improving patient compliance—studies show higher adherence rates with this formulation.​\n\nEnhanced Graft Survival: Prolongs organ viability by effectively suppressing cell-mediated and humoral immunity, with clinical data showing reduced biopsy-proven rejection rates.\n\nImproved Tolerability: Lower incidence of nausea and diarrhea due to delayed-release technology, allowing twice-daily dosing without food restrictions.\n\nFlexible Dosing: Equivalent to 720 mg mycophenolate mofetil, but with predictable MPA exposure via enterohepatic recirculation for steady-state efficacy.\n\nPediatric Suitability: Approved for children over 2 years in renal transplants, supporting growth without compromising safety.\n\nCost-Effective Long-Term Option: Balances efficacy and side effect profile, potentially lowering overall healthcare costs from fewer rejections or hospitalizations.​\n\nPatients experience better quality of life, with sustained energy levels and fewer interruptions from acute rejection crises. Its metabolism to MPA via liver glucuronidation ensures reliable pharmacokinetics, even in patients with mild renal impairment.​\n\nSide Effects of Mycophenolate Sodium 360 mg\nWhile highly effective, mycophenolate sodium 360 mg carries risks typical of immunosuppressants, necessitating vigilant monitoring. Common adverse effects stem from its impact on rapidly dividing cells, particularly in the gut and bone marrow.\n\nCommon Side Effects\nGastrointestinal issues like diarrhea, nausea, vomiting, and abdominal pain, affecting up to 30-50% of users.\n\nHeadache, insomnia, and tremor, often mild and transient.\n\nInfections such as urinary tract or respiratory, due to moderated immunity.\n\nHypertension or peripheral edema, manageable with supportive care.\n\nLeukopenia or anemia, requiring periodic blood counts.​\n\nSerious Side Effects\nSevere myelosuppression leading to neutropenia or thrombocytopenia, which can increase infection or bleeding risks.\n\nProgressive multifocal leukoencephalopathy (PML), a rare brain infection linked to JC virus reactivation.\n\nGastrointestinal perforation or bleeding, especially in at-risk patients.\n\nIncreased malignancy risk, including lymphoma or skin cancers, over long-term use.\n\nHypersensitivity reactions like rash or anaphylaxis.​\n\nRegular complete blood counts, viral monitoring (e.g., CMV, BK virus), and skin exams mitigate these risks. Dose reductions or discontinuation may be needed if counts drop significantly.​\n\nMechanism of Action\nMycophenolate sodium 360 mg rapidly hydrolyzes to mycophenolic acid (MPA), a potent, reversible, non-competitive inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). This enzyme catalyzes the rate-limiting step in de novo guanine nucleotide synthesis, depleting guanosine nucleotides essential for T- and B-cell DNA replication. Lymphocytes, reliant on this pathway, undergo proliferation arrest, suppressing both cell-mediated immunity and antibody production.​\n\nMPA also hinders glycosylation of adhesion molecules on lymphocytes and monocytes, impeding their migration to graft sites. It reduces nitric oxide production in macrophages without affecting endothelial cells, curbing inflammation. Enterohepatic recirculation of the glucuronide metabolite (MPAG) prolongs MPA exposure, enhancing efficacy. Protein binding to albumin (around 97%) ensures targeted delivery, with clearance primarily renal for the inactive form.​\n\nDosage and Administration Guidelines\nStandard dosing for renal transplant is 720 mg (two 360 mg tablets) twice daily, starting within 72 hours post-surgery. Adjustments occur for hepatic or cardiac transplants, often alongside cyclosporine. Therapeutic drug monitoring of MPA AUC (area under curve) optimizes levels between 30-60 mcg·h/mL. Take on an empty stomach for best absorption, though food has minimal impact due to the coating.​\n\nPrecautions and Warnings\nAvoid in pregnancy (Category D) due to teratogenicity—use contraception and regular pregnancy tests. Contraindicated in active untreated infections. Monitor for GI bleeding in ulcerative colitis patients. Drug interactions with antacids, cholestyramine, or rifampin alter MPA levels. Live vaccines are prohibited.​\n\nConclusion\nMycophenolate sodium 360 mg represents a vital advancement in transplant immunosuppression, offering robust protection against rejection with a favorable benefit-risk profile. Its targeted action on lymphocytes, combined with improved GI tolerance, empowers patients to thrive post-transplant. By integrating it into comprehensive regimens with close monitoring, healthcare teams maximize graft success and patient well-being. Always consult a specialist for personalized guidance to harness its full potential safely.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-s-360-133670\n\n\n\n\n\n\n", "price": 767.0, "discountamount": 567.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "dose", "risk", "body", "part", "ORDER", "360mg", "Email", "cells", "dosage", "nausea", "vomiting", "schedule", "headache", "strength", "WhatsApp", "diarrhea", "activity", "rejection", "treatment", "infections", "supplements", "information", "MYCOPLASM S", "sterispharma", "sterisonline", "stomach pain", "blood counts", "immune system", "complications", "liver problems", "liver function", "other medications", "Regular monitoring", "medical conditions", "healthcare provider", "Common side effects", "Serious side effects", "white blood cell count", "potential drug interactions", "optimal therapeutic effects", "combination therapy regimen", "organ transplant recipients", "Mycophenolate Sodium therapy", "other immunosuppressive drugs" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1474, "imageuri": "https://productimages.withfloats.com/actual/6661a739c749b7962dbc08c6.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a739c749b7962dbc08c6.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:10:30.488Z", "updatedon": "2026-03-12T08:02:36.733Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mycophenolate-sodium-360-mg/1474", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM S 360 ", "category": "Oncology", "tags": [ "MYCOPLASM S 360", "Mycophenolate sodium (360mg)", "Mycophenolate sodium 360 mg price", "Mycophenolate sodium 360 mg brands", "Mycophenolate sodium 360 mg side effects", "Myfortic 360 alternative", "Myfortic 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6635ed538e18ce14f428c0c1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tofacitinib 11 mg", "description": "TACOTINIB ER 11 \nTACOTINIB ER 11 (Tofacitinib 11 mg Extended Release) – Comprehensive Product Overview\n\nTACOTINIB ER 11 contains Tofacitinib 11 mg in an extended-release formulation designed for convenient once-daily dosing. Tofacitinib belongs to a class of medicines known as Janus kinase (JAK) inhibitors. It works by modulating the immune system to reduce inflammation and control symptoms in certain autoimmune conditions. TACOTINIB ER 11 is prescribed under medical supervision to help patients manage chronic inflammatory diseases effectively and improve quality of life.\n\nWhat is Tofacitinib 11 mg?\n\nTofacitinib is an oral targeted synthetic disease-modifying anti-rheumatic drug (tsDMARD). Unlike traditional immunosuppressive therapies, it specifically blocks JAK enzymes involved in the inflammatory signaling pathway. By inhibiting these pathways, TACOTINIB ER 11 reduces the overactive immune response responsible for joint damage, swelling, pain, and other systemic symptoms.\n\nThe extended-release (ER) 11 mg formulation ensures a steady release of medication over 24 hours, maintaining consistent blood levels while improving convenience compared to twice-daily immediate-release options.\n\nIndications and Uses of TACOTINIB ER 11\n\nTACOTINIB ER 11 is commonly prescribed for the management of:\n\n1. Rheumatoid Arthritis (RA)\n\nA chronic autoimmune condition that causes inflammation in the joints, leading to pain, stiffness, swelling, and progressive joint damage. Tofacitinib helps reduce inflammation and slow structural damage.\n\n2. Psoriatic Arthritis (PsA)\n\nAn inflammatory arthritis associated with psoriasis. TACOTINIB ER 11 helps manage joint symptoms and improves physical function.\n\n3. Ulcerative Colitis (UC)\n\nA chronic inflammatory bowel disease affecting the colon. Tofacitinib may help reduce intestinal inflammation and induce remission in moderate to severe cases.\n\n4. Ankylosing Spondylitis (AS) (as advised by a physician)\n\nMay be used in selected patients where other treatments are not effective.\n\nTreatment should always be initiated and monitored by a qualified healthcare professional.\n\nHow TACOTINIB ER 11 Works\n\nTACOTINIB ER 11 targets intracellular signaling pathways involved in immune cell activation. By blocking Janus kinase enzymes (JAK1 and JAK3 primarily), it prevents the transmission of pro-inflammatory cytokine signals. This results in:\n\nReduced joint inflammation\n\nDecreased immune overactivity\n\nRelief from pain and stiffness\n\nSlowing of disease progression\n\nBecause it acts on immune pathways, regular medical monitoring is required during treatment.\n\nKey Benefits of TACOTINIB ER 11\n✔ Effective Inflammation Control\n\nReduces swelling, pain, and tenderness in affected joints or tissues.\n\n✔ Improved Physical Function\n\nEnhances mobility and daily activity performance in patients with rheumatoid or psoriatic arthritis.\n\n✔ Convenient Once-Daily Dosing\n\nExtended-release 11 mg formulation improves patient compliance.\n\n✔ Targeted Mechanism of Action\n\nSpecifically inhibits JAK pathways, offering a modern therapeutic approach.\n\n✔ Reduced Disease Progression\n\nHelps prevent long-term structural joint damage when used appropriately.\n\n✔ Oral Administration\n\nUnlike some biologic therapies, TACOTINIB ER 11 is taken orally, eliminating the need for injections.\n\nDosage and Administration\n\nThe usual recommended dose is one tablet (11 mg) once daily, or as prescribed by your physician.\n\nTablets should be swallowed whole with water.\n\nDo not crush, chew, or split the tablet.\n\nCan be taken with or without food.\n\nDosage adjustments may be required in patients with liver impairment, kidney problems, or when used alongside certain medications.\n\nPossible Side Effects of TACOTINIB ER 11\n\nLike all medications, TACOTINIB ER 11 may cause side effects. Not everyone experiences them, but it is important to be aware of potential risks.\n\nCommon Side Effects:\n\nUpper respiratory tract infections\n\nHeadache\n\nDiarrhea\n\nNausea\n\nIncreased cholesterol levels\n\nMild increase in liver enzymes\n\nSerious Side Effects:\n\nSerious infections (tuberculosis, bacterial, viral, or fungal infections)\n\nBlood clots (deep vein thrombosis or pulmonary embolism)\n\nCardiovascular events in high-risk individuals\n\nReduced white blood cell count\n\nIncreased risk of certain cancers (with long-term use)\n\nSeek immediate medical attention if you experience:\n\nPersistent fever\n\nShortness of breath\n\nChest pain\n\nSevere abdominal pain\n\nUnusual bruising or bleeding\n\nRegular blood tests are required to monitor liver function, cholesterol levels, and blood cell counts during treatment.\n\nPrecautions and Warnings\n\nBefore starting TACOTINIB ER 11, inform your doctor if you:\n\nHave a history of recurrent infections\n\nHave liver or kidney disease\n\nHave tuberculosis or hepatitis\n\nAre pregnant or planning pregnancy\n\nAre breastfeeding\n\nHave a history of blood clots or cardiovascular disease\n\nVaccinations should be updated before initiating therapy. Live vaccines are generally not recommended during treatment.\n\nDrug Interactions\n\nTACOTINIB ER 11 may interact with:\n\nStrong CYP3A4 inhibitors (e.g., certain antifungals)\n\nImmunosuppressive drugs\n\nBiologic DMARDs\n\nCertain antibiotics\n\nAlways inform your healthcare provider about all medications and supplements you are taking.\n\nStorage Instructions\n\nStore below 25°C in a dry place\n\nProtect from moisture and direct sunlight\n\nKeep out of reach of children\n\nWho Should Avoid TACOTINIB ER 11?\n\nThis medication may not be suitable for:\n\nPatients with active serious infections\n\nIndividuals with severe liver impairment\nPatients at high risk of blood clots without proper medical supervision\nA detailed medical evaluation is necessary before starting therapy.\n\nConclusion\nTACOTINIB ER 11 (Tofacitinib 11 mg Extended Release) is an advanced oral treatment option for managing moderate to severe autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. By targeting JAK pathways, it effectively reduces inflammation, improves mobility, and enhances overall quality of life.\n", "price": 795.0, "discountamount": 239.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "class", "headache", "response", "guidance", "monitoring", "medication", "TACOTINIB ER", "inflammation", "Janus kinase", "immune system", "joint function", "JAK) inhibitors", "sustained relief", "prescribed dosage", "healthcare provider", "psoriatic arthritis", "Common side effects", "rheumatoid arthritis", "extended-release formulation", "Tofacitinib Extended Release", "gastrointestinal disturbances", "upper respiratory tract infections" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1102, "imageuri": "https://productimages.withfloats.com/actual/6635ed8ae837fe0918c055ff.png", "tileimageuri": "https://productimages.withfloats.com/tile/6635ed8ae837fe0918c055ff.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-04T08:09:55.768Z", "updatedon": "2026-03-14T06:26:01.73Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tofacitinib-11-mg/1102", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TACOTINIB ER 11", "category": "ORTHOLOGYRANG", "tags": [ "tofacitinib 11 mg", "tofacitinib 11 mg tablet", "tofacitinib 11 mg price", "tab tofacitinib 11 mg", "tofacitinib 11 mg uses", "Tofacitinib 11 mg extended release tablets", "Tofacitinib 11 mg ER for psoriatic arthritis treatment", "Tofacitinib 11 mg tablet uses and benefits", "Tofacitinib 11 mg ER dosage guide", "Tofacitinib 11 mg side effects and precautions", "Tofacitinib 11 mg daily autoimmune treatment" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "663213d258d64f20bcad4026", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MESALMILE OD", "description": "MESALMILE OD\nMesalamine PR (1200mg)\nMesalmile OD (Mesalamine PR 1200mg) is a potent, extended-release medication formulated for the treatment of ulcerative colitis. Each tablet contains 1200mg of Mesalamine, an anti-inflammatory drug that targets the colon to reduce inflammation, ulcers, and diarrhea associated with the disease. This once-daily oral tablet helps maintain long-term remission, improve quality of life, and minimize the need for steroids. Ideal for adults managing mild to moderate symptoms, Mesalmile OD is a cornerstone in colitis care, promoting intestinal healing and symptom relief with a well-tolerated profile.\n", "price": 288.0, "discountamount": 87.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "need", "life", "colon", "ulcers", "1200mg", "adults", "quality", "disease", "steroids", "diarrhea", "treatment", "cornerstone", "oral tablet", "inflammation", "colitis care", "MESALMILE OD", "Mesalamine PR", "symptom relief", "tolerated profile", "intestinal healing", "ulcerative colitis", "long-term remission", "anti-inflammatory drug", "mild to moderate symptoms", "potent, extended-release medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 938, "imageuri": "https://productimages.withfloats.com/actual/663213d42a7a7008cb61af09.png", "tileimageuri": "https://productimages.withfloats.com/tile/663213d42a7a7008cb61af09.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-01T10:05:06.499Z", "updatedon": "2026-03-16T06:41:49.711Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mesalmile-od/938", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Mesalamine PR (1200mg)", "category": "GASTROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "663212ea3661c211fc3f00f4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MESALMILE 800 ER ", "description": "MESALMILE 800 ER \nMesalamine (800mg)\nMesalmile 800 ER contains Mesalamine (800mg), a medication designed to treat mild to moderate ulcerative colitis by reducing inflammation in the colon and rectum. This extended-release formula ensures a slow and steady release of the active ingredient, maximizing its efficacy while minimizing potential side effects. Mesalmile 800 ER is ideal for maintaining long-term remission and managing symptoms like diarrhea, rectal bleeding, and abdominal pain. Always use under medical supervision.", "price": 260.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "slow", "800mg", "colon", "rectum", "mild to", "diarrhea", "efficacy", "symptoms", "Mesalamine", "medication", "inflammation", "steady release", "abdominal pain", "rectal bleeding", "MESALMILE 800 ER", "active ingredient", "medical supervision", "long-term remission", "potential side effects", "extended-release formula", "moderate ulcerative colitis" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 937, "imageuri": "https://productimages.withfloats.com/actual/663212eee837fe0918bd3ecb.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/663212eee837fe0918bd3ecb.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-01T10:01:14.849Z", "updatedon": "2026-03-12T07:24:25.649Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mesalmile-800-er-/937", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Mesalamine (800mg)", "category": "GASTROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "663210baae1cfd0bbc280ae3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MESALMILE 500 PR ", "description": "MESALMILE 500 PR \nMesalamine DR (500mg)\nMesalmile 500 PR/Mesalamine DR (500mg): Mesalmile 500 PR, featuring delayed-release Mesalamine (500mg), is a targeted treatment for mild to moderate ulcerative colitis. Its advanced formulation ensures the active ingredient is released directly in the colon, maximizing efficacy while minimizing common gastrointestinal side effects. Ideal for long-term management, it helps reduce inflammation, promoting mucosal healing and symptom relief. Suitable for adults and monitored use in children.", "price": 256.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "use", "colon", "adults", "mild to", "delayed", "children", "efficacy", "inflammation", "symptom relief", "mucosal healing", "active ingredient", "release Mesalamine", "targeted treatment", "long-term management", "advanced formulation", "moderate ulcerative colitis", "Mesalmile 500 PR/Mesalamine DR", "common gastrointestinal side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 936, "imageuri": "https://productimages.withfloats.com/actual/663210bcc76b7398ff844baf.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/663210bcc76b7398ff844baf.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-01T09:51:54.384Z", "updatedon": "2026-03-14T10:46:21.651Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mesalmile-500-pr-/936", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Mesalamine DR (500mg)", "category": "GASTROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66320fe958d64f20bcad3fa5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MESALMILE 400 ", "description": "MESALMILE 400 \nMesalamine ER (400mg)\nMesalamile 400, featuring Mesalamine ER (400mg), is designed to effectively manage ulcerative colitis. This extended-release formulation ensures a steady release of medication, targeting the colon to reduce inflammation, minimize symptoms, and promote healing. Ideal for long-term use, it helps maintain remission and improve quality of life for those with mild to moderate conditions. Always use under medical supervision.", "price": 88.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "colon", "400mg", "healing", "mild to", "quality", "symptoms", "remission", "MESALMILE", "medication", "Mesalamile", "inflammation", "long-term use", "Mesalamine ER", "steady release", "ulcerative colitis", "moderate conditions", "medical supervision", "extended-release formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 935, "imageuri": "https://productimages.withfloats.com/actual/66320fec487940e6c62b10fe.png", "tileimageuri": "https://productimages.withfloats.com/tile/66320fec487940e6c62b10fe.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-01T09:48:25.193Z", "updatedon": "2026-03-14T10:49:39.606Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mesalmile-400-/935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Mesalamine ER (400mg)", "category": "GASTROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "68bc22e83c3803d861d696a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cefpodoxime Proxetil Tablets IP 200 mg", "description": "CEPHODOXIAA 200 is a broad-spectrum oral antibiotic from Steris Healthcare Pvt. Ltd., containing Cefpodoxime Proxetil 200 mg. It belongs to the third-generation cephalosporin class, designed to combat a wide range of bacterial infections effectively. With its high bioavailability, safety profile, and proven efficacy, it is trusted in clinical practice for managing both respiratory and urinary tract infections.\nUsage and Benefits\nCEPHODOXIAA 200 is prescribed for the treatment of bacterial infections caused by susceptible microorganisms, including:\n\nRespiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis, tonsillitis)\n\nUrinary tract infections (cystitis, pyelonephritis)\n\nEar infections (otitis media)\n\nSkin and soft tissue infections\n\nCertain sexually transmitted infections (like gonorrhea)\n\nCommunity-acquired infections where cephalosporins are indicated\n\nBenefits:\n\nBroad-spectrum antibacterial activity against gram-positive and gram-negative organisms\n\nHigh tolerability and oral bioavailability\n\nConvenient twice-daily dosing\n\nEffective alternative when resistance to other antibiotics is suspected\n\nDosage and Administration\nAdults: Typical dose is 200 mg every 12 hours, depending on the severity of the infection.\n\nChildren: Dose is weight-adjusted, usually prescribed in suspension form.\n\nDuration: Treatment typically lasts 5–14 days depending on the infection type and clinical response.\n\nAdministration Tips:\n\nTake with food to enhance absorption.\n\nComplete the full course even if symptoms improve early.\n\nDo not double the dose if a dose is missed—take it as soon as remembered unless it is nearly time for the next dose.\n\nSide Effects\nLike all medicines, CEPHODOXIAA 200 may cause mild to moderate side effects. Common ones include:\n\nGastrointestinal upset (nausea, diarrhea, abdominal pain)\n\nHeadache or dizziness\n\nSkin rash or itching\n\nRare but serious side effects:\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nPseudomembranous colitis (persistent diarrhea)\n\nLiver enzyme elevations\n\nDrug Interactions\nAntacids & H2 blockers: May reduce absorption of Cefpodoxime. Take at least 2–3 hours apart.\n\nBlood thinners (e.g., warfarin): May increase risk of bleeding.\n\nOther antibiotics: Avoid concurrent use unless directed by a doctor to prevent resistance.\n\nAlways inform your physician of all medications and supplements you are taking before starting therapy.\n\nConclusion\nCEPHODOXIAA 200 (Cefpodoxime Proxetil 200 mg) from Steris Healthcare Pvt. Ltd. is a reliable, broad-spectrum antibiotic used in the management of common bacterial infections. With its excellent safety profile, ease of oral administration, and clinical efficacy, it remains a preferred choice for doctors worldwide. Patients should adhere strictly to prescribed dosage and complete the treatment course to ensure optimal results and prevent antibiotic resistance.", "price": 173.0, "discountamount": 52.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2173, "imageuri": "https://productimages.withfloats.com/actual/69294e18b456de02c99ff75f.png", "tileimageuri": "https://productimages.withfloats.com/tile/69294e18b456de02c99ff75f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-06T12:02:48.098Z", "updatedon": "2026-05-25T06:48:30.738Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cefpodoxime-proxetil-tablets-ip-200-mg/2173", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CEPHODOXIAA 200", "category": "GENERAL RANGE", "tags": [ "Cefpodoxime Proxetil 200 mg", "urinary tract infections", "Cefpodoxime Proxetil Tablets IP 200 mg", "Buy Cefpodoxime Proxetil 200 mg Tablets Online", "Cefpodoxime Proxetil 200 mg Antibiotic Tablets", "Cefpodoxime 200 mg Tablets for Bacterial Infection", "Cefpodoxime Proxetil IP 200 mg Medicine", "Broad Spectrum Antibiotic Cefpodoxime Tablets", "Cefpodoxime Proxetil Tablets for Respiratory Infections", "Cefpodoxime Proxetil 200 mg Product Image", "Best Antibiotic Tablets for Bacterial Infection", "Prescription Antibiotic Medicine Cefpodoxime 200 mg", "Cefpodoxime Tablets for Throat and Chest Infection", "Cefpodoxime Proxetil Tablets for UTI Treatment", "Buy Cefpodoxime Antibiotic Tablets Online", "Cefpodoxime Proxetil Tablets for Infection Treatment", "cefpodoxime proxetil tablets uses", "cefpodoxime proxetil tablets", "cefpodoxime proxetil tablets ip 200 mg uses in hindi", "cefpodoxime proxetil tablets ip 200 mg", "cefpodoxime proxetil tablets ip", "cefpodoxime proxetil tablets ip 200 mg uses", "cefpodoxime proxetil tablets ip uses in hindi", "what is the use of cefpodoxime proxetil tablets", "cefpodoxime proxetil tablets ip 200 mg price", "cefpodoxime proxetil tablets 200mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666438e1ea22b014e8af4e56", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MESALMILE OD", "description": "MESALMILE OD\nMesalamine PR (1200mg)\nMesalmile OD is a medication containing Mesalamine PR (1200mg), which is a type of anti-inflammatory drug used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. Mesalamine is also known as 5-aminosalicylic acid (5-ASA) and works by reducing inflammation in the digestive tract.\n\nHere are key points about Mesalmile OD (Mesalamine PR 1200mg):\n\nAnti-inflammatory Action: Mesalamine acts locally in the colon and rectum to reduce inflammation, thereby helping to relieve symptoms such as diarrhea, abdominal pain, and rectal bleeding associated with inflammatory bowel diseases.\n\nMaintenance Therapy: It is often used as a maintenance therapy to prevent flare-ups and maintain remission in patients with ulcerative colitis or Crohn's disease.\n\nDelayed-Release Formulation: The PR (prolonged-release) formulation of Mesalamine ensures that the medication is released slowly and steadily throughout the colon, optimizing its therapeutic effects.\n\nSafety Profile: Mesalamine is generally well-tolerated, with common side effects including nausea, headache, and abdominal discomfort. Serious side effects are rare but may include allergic reactions or kidney problems, especially at higher doses.\n\nUsage Guidance: The dosage and duration of treatment with Mesalmile OD should be determined by a healthcare professional based on the individual's condition and response to the medication.\n\nMesalmile OD with Mesalamine PR (1200mg) is an important medication in the management of inflammatory bowel diseases, providing targeted relief and helping patients maintain a better quality of life. It is crucial to follow medical advice and monitoring while using this medication. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mesalmile-od-133782", "price": 288.0, "discountamount": 87.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ASA", "type", "Call", "life", "colon", "ORDER", "Crohn", "Email", "nausea", "rectum", "Dosage", "quality", "WhatsApp", "response", "symptoms", "diarrhea", "duration", "headache", "patients", "flare-ups", "treatment", "condition", "remission", "monitoring", "individual", "management", "key points", "information", "sterispharma", "inflammation", "sterisonline", "MESALMILE OD", "higher doses", "Mesalamine PR", "medical advice", "Usage Guidance", "Safety Profile", "abdominal pain", "targeted relief", "kidney problems", "digestive tract", "rectal bleeding", "ulcerative colitis", "allergic reactions", "common side effects", "therapeutic effects", "Maintenance Therapy", "important medication", "abdominal discomfort", "Serious side effects", "5-aminosalicylic acid", "anti-inflammatory drug", "healthcare professional", "Anti-inflammatory Action", "Delayed-Release Formulation", "inflammatory bowel diseases", "prolonged-release) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1579, "imageuri": "https://productimages.withfloats.com/actual/667d39ac5e58b0758f705e30.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d39ac5e58b0758f705e30.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:56:33.853Z", "updatedon": "2026-03-16T06:41:42.727Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mesalmile-od/1579", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MESALMILE OD", "category": "GASTROLOGYRANGE", "tags": [ "mesalamine prolonged release tablets 1200mg", "", "mesalamine 1200 mg", "mesalamine 1200 mg uses", "MESALMILE OD", "Mesalamine 1200 mg Price", "Mesalamine 1200 mg Uses in Hindi", "Mesalamine Prolonged Release Tablets 1200mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66643724db9fdd21801f1af0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": " Mesalamine 800mg", "description": "MESALMILE 800 ER \nMesalamine (800mg)\nMESALMILE 800 ER is a medication that contains Mesalamine in an extended-release (ER) formulation, with each tablet containing 800mg of Mesalamine. Mesalamine belongs to a class of medications known as aminosalicylates, which are used to treat various inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.\n\nMesalamine works by reducing inflammation in the colon and rectum. It is believed to inhibit the production of inflammatory chemicals in the body, thus helping to alleviate symptoms such as abdominal pain, diarrhea, and rectal bleeding that are common in inflammatory bowel diseases.\n\nThe extended-release formulation of MESALMILE 800 ER allows for a gradual release of Mesalamine throughout the day, providing sustained relief from symptoms and reducing the frequency of dosing compared to immediate-release formulations.\n\nIt is important to take MESALMILE 800 ER as prescribed by your healthcare provider. Dosage and duration of treatment may vary depending on the severity of your condition and your individual response to the medication. Regular monitoring and follow-up with your healthcare provider are essential to ensure the effectiveness and safety of treatment.\n\nCommon side effects of Mesalamine may include nausea, vomiting, diarrhea, abdominal pain, and headache. Serious side effects such as allergic reactions or worsening of symptoms should be reported to your healthcare provider immediately.\n\nMESALMILE 800 ER is a valuable medication for managing inflammatory bowel diseases, but it should be used under the guidance and supervision of a healthcare professional to optimize its benefits and minimize potential risks.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mesalmile-800-er-133781\n\n\n\n\n\n\n", "price": 243.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Call", "ORDER", "Email", "colon", "Crohn", "class", "800mg", "dosing", "tablet", "Dosage", "safety", "rectum", "nausea", "symptoms", "severity", "diarrhea", "duration", "vomiting", "WhatsApp", "headache", "guidance", "benefits", "follow-up", "frequency", "treatment", "worsening", "condition", "production", "Mesalamine", "information", "supervision", "medications", "sterispharma", "sterisonline", "inflammation", "effectiveness", "abdominal pain", "rectal bleeding", "potential risks", "gradual release", "aminosalicylates", "sustained relief", "MESALMILE 800 ER", "allergic reactions", "ulcerative colitis", "Regular monitoring", "individual response", "healthcare provider", "valuable medication", "Common side effects", "Serious side effects", "inflammatory chemicals", "healthcare professional", "extended-release formulation", "immediate-release formulations", "extended-release (ER) formulation", "various inflammatory bowel diseases" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1578, "imageuri": "https://productimages.withfloats.com/actual/66643727cb17fd7b0aaa1e3d.png", "tileimageuri": "https://productimages.withfloats.com/tile/66643727cb17fd7b0aaa1e3d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T10:49:08.066Z", "updatedon": "2026-03-12T07:24:45.596Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//-mesalamine-800mg/1578", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MESALMILE 800 ER ", "category": "GASTROLOGYRANGE", "tags": [ "MESALMILE 800 ER", "Mesalamine 800mg uses", "Mesalamine (800mg)", "Mesalamine 800mg dosage", "Mesalamine 800mg side effects", "Mesalamine 800mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }